Francesca Barone Candel Therapeutics, Inc. (CADL) insider trading activity
Francesca Barone is Chief Scientific Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 110,673 shares of CADL, which is worth approximately $748,149. The most recent transaction as insider was on Jan 15, 2025, when has been sold 13,534 shares (Common Stock) at a price of $7.22 per share, resulting in proceeds of $97,715. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
111K
30.81%
3M change
40.71%
12M change
Total Value Held
$748,149
Francesca Barone Transaction History
FB
Francesca Barone
Chief Scientific Officer
Needham, MA